Inflammation, microglia, and Alzheimer's disease
Brent Cameron1, Gary E Landreth
1Alzheimer Research Laboratory, Department of Neurosciences, School of Medicine, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.
Neurobiology of Disease
|October 17, 2009
Summary
Microglia, the brain's immune cells, change phenotypes in Alzheimer's disease, responding to amyloid plaques. These diverse microglial responses may involve tissue repair and distinct infiltrating monocytes.
Area of Science:
- Neuroimmunology
- Cellular Biology
- Pathology
Background:
- Microglia are the brain's resident macrophages, crucial for innate immunity, tissue maintenance, and immune surveillance.
- In Alzheimer's disease (AD), amyloid deposition triggers microglial activation and the release of pro-inflammatory molecules.
- Toll-like receptors are implicated in microglial recognition and response to amyloid fibrils.
Purpose of the Study:
- To explore the complex and heterogeneous phenotypes of microglia in the context of Alzheimer's disease.
- To investigate the plasticity and activation state transitions of microglia.
- To examine the potential infiltration of circulating monocytes into the diseased brain and their functional distinction from endogenous microglia.
Main Methods:
- Phenotypic analysis of microglia in Alzheimer's disease models.
- Investigation of microglial responses to amyloid fibrils.
- Assessment of monocyte infiltration and characterization of myeloid cell subpopulations in the brain.
Main Results:
- Microglia exhibit diverse and complex phenotypes in the AD brain, reflecting plasticity and transitions between activation states.
- These phenotypic changes are associated with the inactivation of inflammatory responses and the initiation of tissue repair processes.
- Evidence suggests that circulating monocytes can infiltrate the diseased brain, potentially forming a distinct myeloid cell population.
Conclusions:
- Microglial responses in Alzheimer's disease are more complex than previously understood, involving phenotypic heterogeneity and plasticity.
- The interplay between microglia and infiltrating monocytes may represent a critical aspect of neuroinflammation and repair in AD.
- Understanding these distinct myeloid cell populations is crucial for developing targeted therapeutic strategies for Alzheimer's disease.
More Related Videos
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...